E-LIB Suche - Ergebnisse für: Hanf, Rémy

1

THU-174 Assessment of the pharmacokinetic drug-drug interac..:

Pedret-Dunn, Anna ; Mazain, Sarah ; Allan, Richard..
Journal of Hepatology. 80 (2024) - p. S337-S338 , 2024

2

WED-105 Nitazoxanide directly protects from stress-induced ..:

Bobowski-Gerard, Marie ; Debaecker, Simon ; Stankovic Valentin, Nicolas...
Journal of Hepatology. 80 (2024) - p. S191 , 2024

Link: https://doi.org/10.1016/..

3

Mo1591 ASSESSMENT OF THE DRUG-DRUG INTERACTION POTENTIAL OF..:

Pedret-Dunn, Anna ; Mazain, Sarah ; Allan, Richard..
Gastroenterology. 166 (2024) 5 - p. S-1705-S-1706 , 2024

Link: https://doi.org/10.1016/..

4

Mo1585 ASSESSMENT OF THE DRUG-DRUG INTERACTION POTENTIAL OF..:

Pedret-Dunn, Anna ; Mazain, Sarah ; Allan, Richard..
Gastroenterology. 166 (2024) 5 - p. S-1702-S-1703 , 2024

Link: https://doi.org/10.1016/..

5

Nitazoxanide counteracts lipopolysaccharide-induced hepatic..:

Legry, Vanessa ; Bobowski-Gerard, Marie ; Valentin, Nicolas Stankovic...
Journal of Hepatology. 78 (2023) - p. S211-S212 , 2023

Link: https://doi.org/10.1016/..

6

Improvement of hepatic and extrahepatic functions and anti-..:

Legry, Vanessa ; Delataille, Philippe ; Malysiak, Maryse...
Journal of Hepatology. 77 (2022) - p. S359-S360 , 2022

Link: https://doi.org/10.1016/..

7

A randomized placebo-controlled trial of elafibranor in pat..:

Schattenberg, Jörn M. ; Pares, Albert ; Kowdley, Kris V....
Journal of Hepatology. 74 (2021) 6 - p. 1344-1354 , 2021

Link: https://doi.org/10.1016/..

8

Enhanced liver fibrosis test for the non-invasive diagnosis..:

Vali, Yasaman ; Lee, Jenny ; Boursier, Jérôme...
Journal of Hepatology. 73 (2020) 2 - p. 252-262 , 2020

Link: https://doi.org/10.1016/..

9

Bile acids associate with glucose metabolism, but do not pr..:

Chávez-Talavera, Oscar ; Wargny, Matthieu ; Pichelin, Matthieu...
Metabolism. 103 (2020) - p. 154042 , 2020

Link: https://doi.org/10.1016/..

10

Serum levels of miR-34a to rule-out NAFLD in healthy subjec..:

Harrison, Stephen ; Anstee, Quentin ; Ratziu, Vlad...
Journal of Hepatology. 73 (2020) - p. S73-S74 , 2020

Link: https://doi.org/10.1016/..

11

SAT-299-Assessment of NIS4 clinical utility for identificat..:

Hanf, Remy ; Chaumat, Pierre ; Majd, Zouher...
Journal of Hepatology. 70 (2019) 1 - p. e770 , 2019

Link: https://doi.org/10.1016/..

12

LBO-02-Elafibranor, a peroxisome proliferator-activted rece..:

Jörn, PD Dr. Schattenberg ; Parés, Albert ; Kowdley, Kris V....
Journal of Hepatology. 70 (2019) 1 - p. e128 , 2019

Link: https://doi.org/10.1016/..

13

Elafibranor, an Agonist of the Peroxisome Proliferator−Acti..:

Ratziu, Vlad ; Harrison, Stephen A. ; Francque, Sven...
Gastroenterology. 150 (2016) 5 - p. 1147-1159.e5 , 2016

Link: https://doi.org/10.1053/..

14

The dual peroxisome proliferator-activated receptor alpha/d..:

Hanf, Rémy ; Millatt, Lesley J ; Cariou, Bertrand...
Diabetes and Vascular Disease Research. 11 (2014) 6 - p. 440-447 , 2014

Link: https://doi.org/10.1177/..

15

Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist..:

Cariou, Bertrand ; Hanf, Rémy ; Lambert-Porcheron, Stéphanie...
Diabetes Care. 36 (2013) 10 - p. 2923-2930 , 2013

Link: https://doi.org/10.2337/..